李文斐/ 教授

点赞:

同专业博导

同专业硕导

  • -博士生导师

  • -硕士生导师

  • -电子邮箱:

  • -入职时间:2021-02

  • -所在单位:山东大学基础医学院

  • -职务:科研工作者 + 大学教师

  • -学历:研究生(博士后)

  • -办公地点:山东大学趵突泉校区校区电镜楼

  • -性别:女

  • -联系方式:

  • -学位:博士生

  • -职称:教授

  • -主要任职:医学结构生物学中心副主任

  • -其他任职:Deputy Director, Medical Structural Biology Center

  • -毕业院校:清华大学

  • -学科:生物化学与分子生物学,细胞生物学,生物物理学,遗传学

Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule

发布时间:2021-05-24 点击次数:

论文名称:
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule
发表刊物:
Nature Structural&molecular biology
关键字:
Ribosome Nascent Chain Complex, Cryo-EM, Translation Elongation, PCSK9
摘要:
The drug-like molecule PF-06446846 (PF846) binds the human ribosome and selectively blocks the translation of a small number
of proteins by an unknown mechanism. In structures of PF846-stalled human ribosome nascent chain complexes, PF846
binds in the ribosome exit tunnel in a eukaryotic-specific pocket formed by 28S ribosomal RNA, and alters the path of the
nascent polypeptide chain. PF846 arrests the translating ribosome in the rotated state of translocation, in which the peptidyltransfer
RNA 3!-CCA end is improperly docked in the peptidyl transferase center. Selections of messenger RNAs from mRNA
libraries using translation extracts reveal that PF846 can stall translation elongation, arrest termination or even enhance translation,
depending on nascent chain sequence context. These results illuminate how a small molecule selectively targets translation
by the human ribosome, and provides a foundation for developing small molecules that modulate the production of proteins
of therapeutic interest.
第一作者:
Wenfei Li*
通讯作者:
J. Cate#
全部作者:
Ward, K. McClure, S. Chang, E. Montabana, S. Liras, R. Dullea
卷号:
26
期号:
6
页面范围:
501-509
是否译文:
发表时间:
2019-06
发布期刊链接:
https://www.nature.com/articles/s41594-019-0236-8
发布时间:
2021-05-24